Intermittent Fasting Reduces Crohn's Disease Activity by 40%: What the New RCT Shows
A randomized clinical trial found that eating within an 8-hour window cut Crohn's disease symptoms by 40% and halved inflammation markers in just 12 weeks. Here's what that means for IBD management.
A new randomized controlled trial from the University of Calgary found that time-restricted eating (16:8 fasting) reduced Crohn’s disease activity by 40% and cut abdominal discomfort in half over 12 weeks. Participants also lost weight, reduced visceral fat, and showed improvements in inflammation markers and gut microbiome diversity — all without changing what they ate, only when.
For people living with Crohn’s disease, finding strategies beyond medication to manage symptoms is a constant quest. A new study just added a powerful tool to that toolkit: when you eat may matter just as much as what you eat.
Published in Gastroenterology, this randomized controlled trial is the first to demonstrate significant benefits of intermittent fasting for inflammatory bowel disease (IBD).
The Study: 8-Hour Eating Window, 12 Weeks
Researchers at the University of Calgary enrolled 35 adults with Crohn’s disease who were in remission but had overweight or obesity. They divided participants into two groups:
- Intervention group (20 people): Ate only during an 8-hour window, fasting the remaining 16 hours, for 6 days per week
- Control group (15 people): Ate their regular diet with no timing restrictions
Both groups ate their normal foods — no special diets, no calorie counting. The only difference was when they ate.
Disease activity:
- 40% reduction in stool frequency
- 50% reduction in abdominal discomfort
Body composition:
- TRF group: Lost an average of 2.5kg (5.5 lbs)
- Control group: Gained 1.7kg (3.7 lbs)
- Significant decrease in visceral (belly) fat in the fasting group
Inflammation markers:
- Reduced leptin (a marker of inflammation and fat mass)
- Reduced PAI-1 (a cardiovascular risk marker)
- Improved inflammatory cytokine profiles
Why Timing Matters for Gut Health
What makes this study particularly interesting is that the benefits weren’t simply from eating less. Both groups ate similar amounts of food and had similar diet quality. The changes came from the timing itself.
“We show that clinical symptoms of Crohn’s disease improve with time-restricted eating, as do several systemic markers of inflammation,” said Dr. Maitreyi Raman, the study’s senior author. “Gut microbiome and immune interactions may contribute to intestinal inflammatory homeostasis restoration.”
The Visceral Fat Connection
Visceral fat — the deep abdominal fat surrounding your organs — is particularly inflammatory. It’s not just a storage depot; it actively secretes inflammatory molecules that can worsen conditions like Crohn’s disease.
The fasting group showed meaningful reductions in visceral fat, which the researchers believe explains part of the benefit. Less visceral fat means less inflammatory signalling.
Gut Microbiome Changes
Perhaps most intriguingly, the intervention group showed:
- Greater microbial diversity (generally a sign of gut health)
- Increased short-chain fatty acid (SCFA) producing bacteria
- These SCFAs help regulate gut function and reduce inflammation
What This Means for IBD Management
Dr. Babak Firoozi, a gastroenterologist not involved in the study, put it in perspective:
“Any non-pharmacologic strategy that improves both Crohn’s disease and overall health is meaningful. This study is the first randomized clinical trial to demonstrate a benefit of intermittent fasting in patients with Crohn’s disease.”
The researchers are careful to note this isn’t a replacement for medication — it’s a complementary strategy that could help people maintain remission and improve their overall metabolic health.
Practical Takeaways
If you’re considering time-restricted eating for gut health, here’s what to know:
The Protocol Used
- Eating window: 8 hours (e.g., 10am–6pm or 12pm–8pm)
- Fasting window: 16 hours (including sleep)
- Frequency: 6 days per week (one flexible day)
- Diet: No specific restrictions — participants ate their normal foods
Who This May Help
This study specifically included people with:
- Crohn’s disease in remission
- Overweight or obesity (BMI ≥ 25)
The benefits were most pronounced in those who achieved meaningful weight loss (at least 1 BMI point reduction).
Important Caveats
- Small study: Only 35 participants — larger trials are needed
- 12 weeks: Long-term effects aren’t yet known
- Specific population: Results may not apply to people at healthy weight or with active disease
- Talk to your doctor first: Especially important with IBD, as changes in eating patterns can affect medication timing and absorption
Extended fasting can affect electrolyte balance. Many people find that supplementing with sodium, potassium, and magnesium helps them feel better during fasting periods. This is especially relevant if you have any digestive condition — discuss with your healthcare provider.
The Bigger Picture
This study adds to growing evidence that meal timing is an underappreciated factor in metabolic and gut health. For years, the focus has been almost entirely on what we eat. Now research is showing that when we eat may be equally important.
For the millions of people living with Crohn’s disease and other forms of IBD, having another evidence-based tool in the management toolkit is encouraging news.
As the researchers conclude: “For now, intermittent fasting remains an effective tool to facilitate weight loss and reduce visceral fat in people with overweight and Crohn’s disease, improve clinical symptoms and disease activity, and improve metabolic function.”
Not a cure. Not a replacement for proper medical care. But potentially a meaningful addition to a comprehensive management strategy.
What’s Next
The research team is planning longer-term studies to examine:
- Whether the benefits persist beyond 12 weeks
- Effects on need for surgery and hospitalisation
- Whether this approach helps maintain long-term remission
We’ll be following this research closely. If you’re interested in time-restricted eating, the evidence is building — but as always, work with your healthcare team to find what’s right for your situation.
Sources
- Time Restricted Feeding Reduces Body Mass Index, Visceral Adiposity, Systemic Inflammation, and Clinical Disease Activity in Adults with Crohn's Disease — Gastroenterology (2026-02-09)
- Intermittent fasting cuts Crohn's disease activity by 40% and halves inflammation in randomized clinical trial — Medical Xpress (2026-02-09)
- Time-restricted eating may reduce Crohn's symptoms, inflammation by half — Medical News Today (2026-02-10)